1. Home
  2. NSPR vs KOSS Comparison

NSPR vs KOSS Comparison

Compare NSPR & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • KOSS
  • Stock Information
  • Founded
  • NSPR 2005
  • KOSS 1953
  • Country
  • NSPR Israel
  • KOSS United States
  • Employees
  • NSPR N/A
  • KOSS N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • KOSS Consumer Electronics/Appliances
  • Sector
  • NSPR Health Care
  • KOSS Consumer Staples
  • Exchange
  • NSPR Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • NSPR 63.0M
  • KOSS 68.4M
  • IPO Year
  • NSPR N/A
  • KOSS N/A
  • Fundamental
  • Price
  • NSPR $2.72
  • KOSS $6.62
  • Analyst Decision
  • NSPR Strong Buy
  • KOSS
  • Analyst Count
  • NSPR 2
  • KOSS 0
  • Target Price
  • NSPR $4.75
  • KOSS N/A
  • AVG Volume (30 Days)
  • NSPR 27.8K
  • KOSS 148.4K
  • Earning Date
  • NSPR 03-05-2025
  • KOSS 01-30-2025
  • Dividend Yield
  • NSPR N/A
  • KOSS N/A
  • EPS Growth
  • NSPR N/A
  • KOSS N/A
  • EPS
  • NSPR N/A
  • KOSS N/A
  • Revenue
  • NSPR $6,821,000.00
  • KOSS $12,092,999.00
  • Revenue This Year
  • NSPR $13.36
  • KOSS N/A
  • Revenue Next Year
  • NSPR $49.64
  • KOSS N/A
  • P/E Ratio
  • NSPR N/A
  • KOSS N/A
  • Revenue Growth
  • NSPR 24.70
  • KOSS N/A
  • 52 Week Low
  • NSPR $1.81
  • KOSS $2.27
  • 52 Week High
  • NSPR $3.42
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 47.01
  • KOSS 38.21
  • Support Level
  • NSPR $2.50
  • KOSS $6.58
  • Resistance Level
  • NSPR $2.83
  • KOSS $7.27
  • Average True Range (ATR)
  • NSPR 0.20
  • KOSS 0.45
  • MACD
  • NSPR -0.01
  • KOSS -0.14
  • Stochastic Oscillator
  • NSPR 41.54
  • KOSS 3.48

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: